Literature DB >> 12629367

Relationship of bladder dysfunction to lesion site in multiple sclerosis.

Isao Araki1, Makoto Matsui, Kyoko Ozawa, Masayuki Takeda, Sadako Kuno.   

Abstract

PURPOSE: We investigated the relationship of voiding dysfunction type and the lesion site in patients with multiple sclerosis.
MATERIALS AND METHODS: Voiding dysfunction was evaluated in 32 patients with multiple sclerosis using the International Prostate Symptom Score and urodynamic tests. Lesion sites were determined by combined neurological examination and magnetic resonance imaging findings.
RESULTS: Compared with reports from Western countries the ratio of emptying-to-filling symptoms was high in Japan. Of urinary symptoms only filling correlated with disability status and disease duration. Urinary symptoms were not related to lesion sites. Urodynamic evaluation revealed detrusor hyperreflexia in 14 of 32 patients, hyporeflexia or areflexia in 12, detrusor hyperreflexia with impaired contractile function in 4, a low compliance bladder in 1 and normal function in 1. Of 14 patients with hyperreflexia 13 had overactive sphincter concurrently. Incompetent sphincter was identified in 2 patients who had detrusor hyperreflexia with impaired contractility and in 1 with a low compliance bladder. A significant correlation was noted for a pontine lesion and detrusor hyporeflexia, and for a cervical cord lesion and detrusor-sphincter dyssynergia.
CONCLUSIONS: Detrusor hyporeflexia and detrusor-sphincter dyssynergia are indicative of a pontine and cervical spinal cord lesion, respectively. Thus, the lesion site in the central nervous system may be a major determinant of the type of bladder and urethral sphincter dysfunction. The high prevalence of emptying symptoms in Japanese patients may reflect the prevalence of detrusor hyporeflexia and detrusor-sphincter dyssynergia.

Entities:  

Mesh:

Year:  2003        PMID: 12629367     DOI: 10.1097/01.ju.0000049644.27713.c8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  26 in total

1.  Neurogenic Causes of Detrusor Underactivity.

Authors:  Brian T Kadow; Pradeep Tyagi; Christopher J Chermansky
Journal:  Curr Bladder Dysfunct Rep       Date:  2015-09-15

2.  A new look at detrusor underactivity: impaired contractility versus afferent dysfunction.

Authors:  Anne M Suskind; Phillip P Smith
Journal:  Curr Urol Rep       Date:  2009-09       Impact factor: 3.092

Review 3.  Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.

Authors:  Oussama El Yazami Adli; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2014-01       Impact factor: 1.862

Review 4.  Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines.

Authors:  Shachar Moshe Aharony; Ornella Lam; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

Review 5.  Voiding dysfunction due to detrusor underactivity: an overview.

Authors:  Marcus J Drake; Jonathan Williams; Dominika A Bijos
Journal:  Nat Rev Urol       Date:  2014-07-08       Impact factor: 14.432

Review 6.  Exercise and multiple sclerosis.

Authors:  Lesley J White; Rudolph H Dressendorfer
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 7.  Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.

Authors:  Kevin G Burfeind; Vijayshree Yadav; Daniel L Marks
Journal:  Curr Neurol Neurosci Rep       Date:  2016-11       Impact factor: 5.081

8.  Micturitional disturbance due to bilateral medial frontal lobe lesions in a patient with multiple sclerosis.

Authors:  Sachiko Namatame; Hitoshi Mochizuki; Masahiro Ebitani; Nozomu Matsuda; Yoshikazu Ugawa
Journal:  Neurol Sci       Date:  2010-04       Impact factor: 3.307

9.  The impact of pontine disease on lower urinary tract symptoms in patients with multiple sclerosis.

Authors:  Steven J Weissbart; Dasha Pechersky; Anna Malykhina; Thomas Bavaria; Lisa Parrillo; Lily A Arya; Michel Bilello; Alan J Wein; Ariana L Smith
Journal:  Neurourol Urodyn       Date:  2016-01-06       Impact factor: 2.696

Review 10.  Management of neurogenic bladder in patients with multiple sclerosis.

Authors:  Véronique Phé; Emmanuel Chartier-Kastler; Jalesh N Panicker
Journal:  Nat Rev Urol       Date:  2016-03-31       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.